A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors
Clinical trial NCT06092268 · UNKNOWN
Trial details
- NCT number
- NCT06092268
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2025-12-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.